[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f-AN57-gNXZgxYrkqiOyIU7pgJZayaNnLMF83aGpU9UY":8,"$fss17d95Z3cMUtJgib0kXAd5atPgu1B59TnvxQkLxLk4":54,"$fQLVl_oWl93kYMfcFYfc2_0vdjuYYBXBQ9K860zSUp9o":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":25,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":22,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},45908,870153,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//7YKHTwzkTmwMgqAUwZhBWneZXcUd5VDb.png","邱晓童","浙江大学医学院附属邵逸夫医院","肿瘤科","主治医师",7,0,"肺癌IV期骨转移相关药品：EGFR靶向药物及治疗用药安全指南","","https://ystcdn.venuertc.com/venue/AI/b74df2e0-53e0-47f1-9f4c-4828614f3703.jpg","\u003Cdiv class=\"material-guide-container\">\n  \u003Cdiv class=\"material-title-section\" id=\"material_title\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌IV期骨转移相关药品：EGFR靶向药物及治疗用药安全指南\u003C/h2>\n    \u003Cp class=\"material-intro\">说起来，EGFR靶向药物（以奥希替尼、埃克替尼等为代表）已经成为不少晚期肺癌骨转移患者的重要选择。这类药物属于分子靶向治疗，通过\"精准锁定\"特定蛋白，改善治疗效果。今天我们来聊聊EGFR靶向药及相关用药过程中必须注意的8个关键细节，让每一位用药者都能做到安心、规范、有效。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 剂型特点及服用技巧 -->\n  \u003Csection class=\"material-section material-bg1\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型与服用技巧\u003C/h2>\n    \u003Cp>\n      EGFR靶向药物多以片剂形式发售，例如奥希替尼、吉非替尼、埃克替尼等。\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>整片吞服并用足量清水送服，\u003Cspan class=\"material-highlight\">不能掰碎、咀嚼或溶解\u003C/span>，以避免影响药效释放。部分药品的剂型为薄膜衣片，更要避免分割。服药时不建议与果汁、碳酸饮料等同服，防止可能的化学反应或影响吸收。\u003Cbr>\n      \u003Cspan class=\"material-emoji\">💊\u003C/span> \n      \u003Cstrong>服药示例：\u003C/strong>如需每天一次，则建议每天固定时间服用，有助于维持体内稳定浓度。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 最佳服药时间与餐食关系 -->\n  \u003Csection class=\"material-section material-bg2\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 服药时间的选择\u003C/h2>\n    \u003Cp>\n      这类靶向药物服药时间相对灵活，与食物关系因药而异。\u003Cbr>\n      \u003Cstrong>奥希替尼：\u003C/strong>可空腹或餐后服用，不会显著影响吸收。\u003Cbr>\n      \u003Cstrong>吉非替尼、埃克替尼：\u003C/strong>建议餐中或餐后服用，以减少胃肠刺激。\u003Cbr>\n      \u003Cspan class=\"material-highlight\">切忌随意更换服药时间。\u003C/span>\u003Cbr>\n      \u003Cspan class=\"material-emoji\">⏰\u003C/span> \n      \u003Cstrong>需要注意：\u003C/strong>若漏服，应尽快补服，如已接近下次服药时间，则跳过漏服剂量，\u003Cspan class=\"material-highlight\">不可一次服用双倍剂量\u003C/span>。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 用法用量与剂量调整 -->\n  \u003Csection class=\"material-section material-bg3\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用法用量与剂量调整\u003C/h2>\n    \u003Cp>\n      说明书推荐剂量为：\n      \u003C/p>\u003Cul class=\"material-list\">\n        \u003Cli>奥希替尼：一般为80mg，每日一次\u003C/li>\n        \u003Cli>吉非替尼：250mg，每日一次\u003C/li>\n        \u003Cli>埃克替尼：125mg，每次3片，每日三次\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"material-emoji\">📋\u003C/span> \n      \u003Cstrong>实际调整：\u003C/strong>如果出现无法耐受的不良反应，\u003Cspan class=\"material-highlight\">必须在医生指导下调整剂量\u003C/span>。自己不得随意减量、停药或加量。不良反应包括皮疹、腹泻等，严重时需停药观察，待症状缓解后再考虑恢复或调整剂量。\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 药物相互作用及并用禁忌 -->\n  \u003Csection class=\"material-section material-bg1\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用与并用禁忌\u003C/h2>\n    \u003Cp>\n      EGFR靶向药物与其他药物合用时要格外谨慎。\u003Cbr>\n      \u003Cspan class=\"material-emoji\">⚠️\u003C/span>\n      \u003Cstrong>主要相互作用：\u003C/strong>\n      \u003C/p>\u003Cul class=\"material-list\">\n        \u003Cli>质子泵抑制剂、H2受体阻断剂可能降低吉非替尼吸收，最好间隔2小时以上服用。\u003C/li>\n        \u003Cli>某些抗真菌药（例如酮康唑）、部分抗癫痫药（如卡马西平）可改变血药浓度，需要监测。\u003C/li>\n        \u003Cli>含有葡萄柚的食品和饮品会影响部分药物代谢，\u003Cspan class=\"material-highlight\">建议避免食用\u003C/span>。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>不能同时服用：\u003C/strong>对说明书明确禁用的药物，应严格避免。\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 特殊人群用药及剂量注意事项 -->\n  \u003Csection class=\"material-section material-bg2\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群的用药调整\u003C/h2>\n    \u003Cp>\n      \u003Cspan class=\"material-emoji\">👴\u003C/span> \n      \u003Cstrong>老年人：\u003C/strong>一般无须常规调整，但若合并肝肾功能减退或体重偏低，需要个体化剂量。\u003Cbr>\n      \u003Cstrong>肝肾功能受损者：\u003C/strong>中重度受损时部分药品建议减量或慎用。\u003Cbr>\n      \u003Cstrong>孕妇、哺乳期妇女：\u003C/strong>用药前须咨询医生，因部分药品存在胎毒/乳汁分泌风险。\u003Cbr>\n      \u003Cspan class=\"material-highlight\">具体剂量调整详见说明书，并在医生监护下操作。\u003C/span>\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 常见不良反应识别与处理方法 -->\n  \u003Csection class=\"material-section material-bg3\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与处理方案\u003C/h2>\n    \u003Cp>\n      \u003Cspan class=\"material-emoji\">🚩\u003C/span>\n      \u003Cstrong>主要不良反应：\u003C/strong>\n      \u003C/p>\u003Cul class=\"material-list\">\n        \u003Cli>皮疹、干燥、色素沉着\u003C/li>\n        \u003Cli>腹泻、恶心、食欲减退\u003C/li>\n        \u003Cli>极少见者出现间质性肺炎症状（紧急就医）\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong>\n      出现轻至中度副作用时，可短暂停药并对症处理；出现持续高热、呼吸异常等严重反应时，应立即停药并就医。\n      \u003Cbr>\n      \u003Cspan class=\"material-highlight\">不得自行通过加减剂量来“对冲”副作用。\u003C/span>\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 储存方式及有效期管理 -->\n  \u003Csection class=\"material-section material-bg1\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存与有效期管理\u003C/h2>\n    \u003Cp>\n      \u003Cspan class=\"material-emoji\">🗄️\u003C/span>\n      \u003Cstrong>正确保存：\u003C/strong>\n      置于阴凉干燥处，避免阳光直射和高温，温度建议控制在20-25°C，避免儿童触及。部分特殊剂型的药物需避光密封保存，开封后建议1-2月内用完。\u003Cbr>\n      \u003Cstrong>过期处理：\u003C/strong>\n      \u003Cspan class=\"material-highlight\">药品过期绝不可服用\u003C/span>，请交由药店或正规回收点妥善处理，不要随意丢弃。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 漏服和过量应对方法 -->\n  \u003Csection class=\"material-section material-bg2\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服与过量处理：应对方法\u003C/h2>\n    \u003Cp>\n      \u003Cspan class=\"material-emoji\">❓\u003C/span>\n      \u003Cstrong>漏服：\u003C/strong>如记起时距离下次服药时间较远，立即补服；如接近下次服药时间，直接跳过，不可加量补服。\u003Cbr>\n      \u003Cstrong>过量：\u003C/strong>极有可能加重肝损伤等副作用，若误服过量，应及时到医院就诊，说明具体用药剂量与时间，医生会给予支持性处理。\u003Cbr>\n      \u003Cspan class=\"material-highlight\">切忌等待观察，过量需及时就医。\u003C/span>\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 临床经典用药案例分享 -->\n  \u003Csection class=\"material-section material-bg3\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">典型用药案例参考\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>一位72岁男性患者，因出现用药后的皮肤不适和轻微腹泻，在医生指导下将EGFR靶向药品的剂量从标准量调至个体可耐受剂量，副作用得到缓解，停药后依从医生建议定期随访，并未自行加减用量。\u003C/li>\n      \u003Cli>临床上有患者在使用吉非替尼期间，与抗酸药同服后药效减弱，经药师建议调整服药间隔，吸收恢复稳定。\u003C/li>\n      \u003Cli>有患者将靶向药与葡萄柚汁同时服用，被及时告知停用葡萄柚制品，避免了药物不良反应加重。\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 药品作用机制简介 -->\n  \u003Csection class=\"material-section material-bg1\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">药品作用简述\u003C/h2>\n    \u003Cp>\n      EGFR靶向药物（如奥希替尼、吉非替尼）属于酪氨酸激酶抑制剂（TKI），能特异性抑制EGFR蛋白酪氨酸激酶活性。这样可减少异常信号传递，从而阻断癌细胞增殖相关途径（\u003Cspan class=\"material-highlight\">Cross et al., 2014\u003C/span>）。\n    \u003C/p>\n    \u003Cp>\n      \u003Cstrong>特别强调：\u003C/strong> 作用机制虽先进，但只有遵医嘱、规范用药，才能真正实现药效最大化与风险最小化。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 结语总结 -->\n  \u003Csection class=\"material-section material-conclusion\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结与用药提醒\u003C/h2>\n    \u003Cp>\n      总体来说，EGFR靶向药物在肺癌IV期骨转移治疗领域具有显著优势，但用药安全必须放在第一位。\u003Cspan class=\"material-highlight\">规范服用剂量、警惕不良反应和药物相互作用、关注独特的保存方式\u003C/span>，是保证药效和减少风险的关键。如果用药中遇到疑惑或异常，及时向专业药师或医生咨询，避免自行处理。合理用药，才能为健康加分。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"material-highlight\">核心建议：用药别随意，调整须专业。\u003C/span>\n    \u003C/p>\n  \u003C/section>\n  \n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"material-section material-bg4\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">引用文献\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>Cross, D. A., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C.A., et al. (2014). AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer. \u003Ci>Cancer Discovery\u003C/i>, 4(9), 1046-1061. https://doi.org/10.1158/2159-8290.CD-14-0337\u003C/li>\n      \u003Cli>Yang, J. C., Wu, Y. L., Schuler, M., Sebastian, M., Popat, S., et al. (2015). Afatinib versus Gefitinib as First-Line Treatment of Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer (LUX-Lung 7): A Phase 2B, Open-Label, Randomised Controlled Trial. \u003Ci>The Lancet Oncology\u003C/i>, 16(7), 830-838. https://doi.org/10.1016/S1470-2045(15)00006-6\u003C/li>\n      \u003Cli>Soria, J. C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., et al. (2018). Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 378(2), 113-125. https://doi.org/10.1056/NEJMoa1713137\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.material-guide-container {\n  font-family: \"Segoe UI\", \"Arial\", \"Microsoft YaHei\", sans-serif;\n  max-width: 890px;\n  margin: 40px auto 80px auto;\n  background: #fff;\n  box-shadow: 0 2px 14px rgba(38,76,106,0.07);\n  border-radius: 18px;\n  padding: 0 52px 32px 52px;\n  line-height: 1.7;\n  color: #222a2f;\n}\n\n.material-title-section {\n  border-radius: 18px 18px 0 0;\n  background: linear-gradient(135deg, #eaf5fc 32%, #e5eefc 100%);\n  margin: 0 -52px 28px -52px;\n  padding: 36px 52px 12px 52px;\n  box-shadow: 0 1px 18px rgba(26,112,183,0.13);\n}\n.material-title-section h1 {\n  font-size: 31px;\n  color: #1c3956;\n  margin-bottom: 15px;\n  letter-spacing: 2px;\n}\n.material-intro {\n  font-size: 18px;\n  color: #34618d;\n}\n\n.material-section {\n  background: #f8fcff;\n  border-radius: 10px;\n  margin-bottom: 24px;\n  padding: 32px 22px 22px 28px;\n  position: relative;\n  box-shadow: 0 1px 4px rgba(77,157,210,0.05);\n}\n.material-bg1 {\n  background: linear-gradient(120deg, #f6feff 0%, #f4f2fd 100%);\n}\n.material-bg2 {\n  background: linear-gradient(115deg, #e4ecfa 20%, #f9f9fc 90%);\n}\n.material-bg3 {\n  background: linear-gradient(100deg, #f1faf6 20%, #f7f7f7 100%);\n}\n.material-bg4 {\n  background: linear-gradient(135deg, #eaf4f6 14%, #fbfafd 95%);\n}\n\n.material-section h2 {\n  color: #245187;\n  font-size: 24px;\n  margin-bottom: 18px;\n  font-weight: 500;\n  letter-spacing: 1.2px;\n}\n\n.material-section p,\n.material-section ul {\n  font-size: 16px;\n}\n\n.material-highlight {\n  background: #ffeedd;\n  color: #973e1c;\n  padding: 0 6px;\n  border-radius: 5px;\n}\n\n.material-emoji {\n  font-size: 23px;\n  padding-right: 3px;\n}\n\n.material-list {\n  margin: 8px 0 8px 18px;\n  padding-left: 14px;\n  list-style: disc;\n}\n\n.material-conclusion {\n  background: linear-gradient(90deg, #fffef6 70%, #f2fbfa 100%);\n  color: #245455;\n  border-left: 5px solid #d0b585;\n  margin-bottom: 18px;\n}\n.material-conclusion h2 {\n  color: #926f20;\n}\n\n@media screen and (max-width: 600px) {\n  .material-guide-container {\n    padding: 0 7px 22px 7px;\n    max-width: 99%;\n  }\n  .material-title-section {\n    margin: 0 -7px 20px -7px;\n    padding: 23px 7px 7px 15px;\n  }\n}\n\u003C/style>\n",523,"2025-07-01 16:46:30","EGFR靶向药物, 肺癌, 骨转移, 药品安全, 用药指南","了解EGFR靶向药物在肺癌IV期骨转移治疗中的重要性及风险管理，掌握用药安全与有效性。专为患者和家庭提供实用建议。","2025-07-04 00:36:00",2,[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]